Becton, Dickinson PE Ratio 2006-2018 | BDX

Current and historical price to earnings ratio for Becton, Dickinson (BDX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Becton, Dickinson as of August 20, 2018 is 24.25.
Becton, Dickinson Annual PE Ratio
Becton, Dickinson Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.726B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $28.698B 76.51
McKesson (MCK) United States $25.846B 9.89
AmerisourceBergen (ABC) United States $18.979B 13.79
Laboratory Of America Holdings (LH) United States $18.565B 17.08
Cardinal Health (CAH) United States $16.125B 10.81
Cooper (COO) United States $12.651B 23.55
Henry Schein (HSIC) United States $12.301B 20.98
DENTSPLY SIRONA (XRAY) United States $8.598B 15.05
West Pharmaceutical Services (WST) United States $8.532B 44.11
Merit Medical Systems (MMSI) United States $3.101B 40.76
Patterson (PDCO) United States $2.237B 14.01
CONMED (CNMD) United States $2.184B 37.01
STAAR Surgical (STAA) United States $1.804B 241.47
Atrion (ATRI) United States $1.213B 35.96
Antares Pharma (ATRS) United States $0.534B 0.00
Invacare (IVC) United States $0.525B 0.00
Endologix (ELGX) United States $0.215B 0.00
Lifevantage (LFVN) United States $0.163B 23.08
Aceto (ACET) United States $0.100B 4.07
Biolase (BIOL) United States $0.037B 0.00
Pro-Dex (PDEX) United States $0.029B 12.69